| Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study |
36 |
| Current perspectives on tree nut allergy: a review |
19 |
| Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers |
12 |
| Non-eosinophilic asthma: current perspectives |
11 |
| Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities |
11 |
| Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab |
10 |
| Late-onset asthma: current perspectives |
9 |
| NSAID-induced reactions: classification, prevalence, impact, and management strategies |
8 |
| Thunderstorm-triggered asthma: what we know so far |
8 |
| Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma |
7 |
| Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis |
7 |
| A purinergic P2Y6 receptor agonist prodrug modulates airway inflammation, remodeling, and hyperreactivity in a mouse model of asthma |
6 |
| Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history |
6 |
| School-based supervised therapy programs to improve asthma outcomes: current perspectives |
6 |
| Prevalence of allergic sensitization, hay fever, eczema, and asthma in a longitudinal birth cohort |
6 |
| Recent Developments In Bronchial Thermoplasty For Severe Asthma |
5 |
| Inadequate quality of administration of intranasal corticosteroid sprays |
5 |
| Prevalence and impact of risk factors for poor asthma outcomes in a large, specialist-managed patient cohort: a real-life study |
5 |
| A systematic review and meta-analysis of the impact of collaborative practice between community pharmacist and general practitioner on asthma management |
5 |
| Characterizing Real-World Use Of Tiotropium In Asthma In The USA |
5 |
| Spotlight on fevipiprant and its potential in the treatment of asthma: evidence to date |
5 |
| Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma |
5 |
| Utility of a thin bronchoscope in facilitating bronchial thermoplasty |
4 |
| Correlation between impulse oscillometry parameters and asthma control in an adult population |
4 |
| Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications |
4 |
| Clinical Utility Of The Exhaled Nitric Oxide (NO) Measurement With Portable Devices In The Management Of Allergic Airway Inflammation And Asthma |
4 |
| Diagnosis of fish and shellfish allergies |
4 |
| Severe bronchial asthma in children: a review of novel biomarkers used as predictors of the disease |
4 |
| Approaches to the assessment of severe asthma: barriers and strategies |
3 |
| Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma |
3 |
| Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial |
3 |
| Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey |
3 |
| Anxiety and Depression in Eosinophilic Esophagitis: A Scoping Review and Recommendations for Future Research |
3 |
| Methacholine challenge testing: comparative pharmacology |
3 |
| Pilot-Scale Study Of Human Plasma Proteomics Identifies ApoE And IL33 As Markers In Atopic Asthma |
3 |
| Rupatadine oral solution for 2-5-year-old children with allergic rhinitis: a safety, open-label, prospective study |
3 |
| Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study |
3 |
| Matched cohort study of therapeutic strategies to prevent preschool wheezing/asthma attacks |
3 |
| Asia-Pacific Survey of Physicians on Asthma and Allergic Rhinitis (ASPAIR): physician beliefs and practices about diagnosis, assessment, and treatment of coexistent disease |
2 |
| 5 Detection of pepsin and IL-8 in saliva of adult asthmatic patients |
2 |
| Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink) |
2 |
| Economic considerations in the treatment of systemic allergic reactions |
2 |
| Intraoperative anaphylaxis to gelatin-based hemostatic agents: a case report |
2 |
| Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma |
2 |
| Parasitic (Helminthic) Infection While on Asthma Biologic Treatment: Not Everything Is What It Seems |
2 |
| Essential oils, asthma, thunderstorms, and plant gases: a prospective study of respiratory response to ambient biogenic volatile organic compounds (BVOCs) |
2 |
| Association of genetic variants with level of asthma control in the Arab population |
2 |
| Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial |
1 |
| Characteristics of patients with severe, uncontrolled, eosinophilic asthma enrolled in a French cohort |
1 |
| Two vs four puffs of albuterol: does dose change bronchodilator response? |
1 |
